NBIC Announce Partnership with Venturefest South The National Biofilms Innovation Centre (NBIC) are pleased to announce a new partnership with Venturefest South (VFS), the fastest-growing innovation and business growth programme in the South. With Venturefest South...
Target Product Profiles for Diagnostics The Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate recently launched their diagnostic target product profiles (TPPs) detailing key characteristics of new tests needed to detect and manage lung infections in CF. A...
A tribute in memory of our colleague and friend Professor Paul Stoodley Paul held the positions of Professor of Microbial Infection and Immunity and Orthopedics at the Ohio State University, and Professor in Microbial Tribology at University of Southampton, among...
Combating antibiotic resistance Antibiotics are used to treat or prevent some types of bacterial infection. They are becoming less effective due to overuse in recent years. NBIC Research Fellow, Dr Callum Highmore, and researchers at the NIHR Southampton Biomedical...
Major Research and Innovation Infrastructure Investment for the University of Liverpool The University of Liverpool will lead a new £125 million national research facility to drive forward scientific discoveries and technological advances in areas such as sustainable...
